Royalty Pharma plc - SIC # 6794 - PATENT OWNERS AND LESSORS

Ticker Exchange SIC # Website Latest Ticker
RPRX Nasdaq 6794 www.royaltypharma.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Royalty Pharma plc

3 Mid-Cap Stocks We Steer Clear Of - May 20th, 2026 4:04 am
Royalty Pharma (RPRX) Benefits from Biotech Funding Gap with Rising Returns and Market Dominance - May 18th, 2026 6:32 am
Royalty Pharma’s Q1 Earnings Call: Our Top 5 Analyst Questions - May 16th, 2026 3:24 am
Anaptys Announces First Quarter 2026 Financial Results and Provides Business Update - May 12th, 2026 2:15 pm
Income Investors Should Know That Royalty Pharma plc (NASDAQ:RPRX) Goes Ex-Dividend Soon - May 11th, 2026 10:12 am
Why One Fund’s $4 Million Centerra Gold Exit Looks Like Profit-Taking Amid a 150% Rally - May 10th, 2026 9:22 am
This Fund Cashed Out of Preformed Line Products Amid a 150% Stock Surge - May 8th, 2026 9:14 am
10% Of This Royalty Pharma Insider's Holdings Were Sold - May 8th, 2026 8:00 am
Royalty Pharma to present at upcoming investor conferences - May 7th, 2026 2:15 pm
Royalty Pharma Q1 Earnings Call Highlights - May 6th, 2026 2:42 pm
Royalty Pharma plc Q1 2026 Earnings Call Summary - May 6th, 2026 11:07 am
RPRX vs. AMGN: Which Stock Is the Better Value Option? - May 6th, 2026 9:40 am
Royalty Pharma PLC (RPRX) Hit a 52 Week High, Can the Run Continue? - May 6th, 2026 7:15 am
Royalty Pharma (RPRX) Q1 Earnings and Revenues Surpass Estimates - May 6th, 2026 7:05 am
Royalty Pharma reports first quarter 2026 results - May 6th, 2026 5:00 am
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar - May 1st, 2026 7:00 am
Codexis (CDXS) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release - Apr 30th, 2026 8:00 am
Royalty Pharma (RPRX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release - Apr 29th, 2026 8:00 am
A Look At Royalty Pharma (RPRX) Valuation After Its Recent Share Price Momentum - Apr 27th, 2026 2:04 am
Zymeworks Highlights Royalty-Fueled Pivot at Bloom Burton, Eyes Multibillion-Dollar Ziihera - Apr 26th, 2026 1:12 am